Vol 13, No 2 (2010)
Case report
Published online: 2011-05-20
Abnormal Tc99m sulesomab in Klippel-Trenaunay syndrome
Nucl. Med. Rev 2010;13(2):84-86.
Abstract
Tc-99m sulesomab is indicated in bone and joint infection, but
reading of scans can be affected by pre-existing conditions. This
case report describes a case of Klippel-Trenaunay syndrome
(KTS) which results in vascular malformations of one or more
limbs. Tc-99m sulesomab imaging demonstrated persistent
blood pool activity up to 20 hours post injection. However,
despite this, septic arthritis could be identified with confidence
in the same limb.
Nuclear Med Rev 2010; 13, 2: 84–86
Nuclear Med Rev 2010; 13, 2: 84–86
Keywords: Klippel-Trenaunay syndromeTc-99m sulesomab